| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.05 |